Lista de obras -

11β-Prostaglandin F2α, a bioactive metabolite catalyzed by AKR1C3, stimulates prostaglandin F receptor and induces slug expression in breast cancer

artículo científico publicado en 2015

17β-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer.

artículo científico publicado en 2018

ARHGAP15 in Human Breast Carcinoma: A Potent Tumor Suppressor Regulated by Androgens.

artículo científico publicado en 2018

Abnormal expression of miR-1 in breast carcinoma as a potent prognostic factor

artículo científico publicado en 2015

Amyloid precursor protein in human breast cancer: an androgen-induced gene associated with cell proliferation

artículo científico publicado en 2013

An induction of microRNA, miR-7 through estrogen treatment in breast carcinoma

artículo científico publicado en 2012

Androgen and androgen-metabolizing enzymes in metastasized lymph nodes of breast cancer

artículo científico publicado en 2013

Androgenic pathway in triple negative invasive ductal tumors: its correlation with tumor cell proliferation.

artículo científico publicado en 2013

Androgens in human breast carcinoma ⬇️

artículo científico publicado el 4 de agosto de 2010

Aryl hydrocarbon receptor in breast cancer—a newly defined prognostic marker

artículo científico publicado en 2014

BUB1 immunolocalization in breast carcinoma: its nuclear localization as a potent prognostic factor of the patients

artículo científico publicado en 2013

CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance

scientific article published on 14 September 2016

Co-expression of carcinoembryonic antigen-related cell adhesion molecule 6 and 8 inhibits proliferation and invasiveness of breast carcinoma cells

artículo científico publicado en 2019

Cytochrome c1 as a favorable prognostic marker in estrogen receptor-positive breast carcinoma

artículo científico publicado en 2019

Cytochrome c1 in ductal carcinoma in situ of breast associated with proliferation and comedo necrosis

artículo científico publicado en 2017

Distinct nuclear receptor expression in stroma adjacent to breast tumors.

artículo científico publicado en 2013

Epigenetic mechanisms regulate the prostaglandin E receptor 2 in breast cancer.

artículo científico publicado en 2012

GATA4 immunolocalization in breast carcinoma as a potent prognostic predictor

artículo científico publicado en 2014

Hexokinase 2 in colorectal cancer: a potent prognostic factor associated with glycolysis, proliferation and migration

artículo científico publicado en 2016

Hexokinase II in breast carcinoma: a potent prognostic factor associated with hypoxia-inducible factor-1α and Ki-67.

artículo científico publicado en 2013

Identification of androgen-responsive microRNAs and androgen-related genes in breast cancer

artículo científico publicado en 2013

Immunolocalization of corticotropin-releasing hormone (CRH) and its receptors (CRHR1 and CRHR2) in human endometrial carcinoma: CRHR1 as a potent prognostic factor.

artículo científico publicado en 2014

Immunolocalization of estrogen-producing and metabolizing enzymes in benign breast disease: comparison with normal breast and breast carcinoma

artículo científico publicado en 2010

Immunolocalization of thymidylate synthase as a favorable prognostic marker in estrogen receptor-positive breast carcinoma.

artículo científico publicado en 2015

Increased intratumoral androgens in human breast carcinoma following aromatase inhibitor exemestane treatment

artículo científico publicado en 2010

Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment

artículo científico publicado en 2017

Intratumoral estrogen concentration and expression of estrogen-induced genes in male breast carcinoma: comparison with female breast carcinoma

artículo científico publicado en 2012

KLF15 in breast cancer: a novel tumor suppressor?

artículo científico publicado en 2015

Krüppel-like factor 5 in human breast carcinoma: a potent prognostic factor induced by androgens

scientific article published on 06 November 2012

Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts

artículo científico publicado en 2012

NRF2 immunolocalization in human breast cancer patients as a prognostic factor

artículo científico publicado en 2014

Nucleobindin 2 (NUCB2) in human endometrial carcinoma: a potent prognostic factor associated with cell proliferation and migration

artículo científico publicado en 2016

Nucleobindin 2 in human breast carcinoma as a potent prognostic factor

artículo científico publicado en 2011

Nudix-type motif 2 in human breast carcinoma: a potent prognostic factor associated with cell proliferation

artículo científico publicado en 2011

OLFM4, LY6D and S100A7 as potent markers for distant metastasis in estrogen receptor-positive breast carcinoma

artículo científico publicado en 2018

Oestrogen-induced genes in ductal carcinoma in situ: their comparison with invasive ductal carcinoma ⬇️

artículo científico publicado el 18 de julio de 2012

Rac1 activation in human breast carcinoma as a prognostic factor associated with therapeutic resistance

artículo científico publicado en 2020

Relaxin 2/RXFP1 Signaling Induces Cell Invasion via the β-Catenin Pathway in Endometrial Cancer

scientific article published on 18 August 2018

Retinoic Acid Receptor β: A Potential Therapeutic Target in Retinoic Acid Treatment of Endometrial Cancer

artículo científico publicado en 2017

Runt-related transcription factor 2 in human colon carcinoma: a potent prognostic factor associated with estrogen receptor

artículo científico publicado en 2012

Runx2 in human breast carcinoma: its potential roles in cancer progression ⬇️

artículo científico publicado el 12 de octubre de 2010

TACC2 (transforming acidic coiled-coil protein 2) in breast carcinoma as a potent prognostic predictor associated with cell proliferation

artículo científico publicado en 2016

The interplay of endocrine therapy, steroid pathways and therapeutic resistance: Importance of androgen in breast carcinoma

artículo científico publicado en 2017

The role of 5α-reductase type 1 associated with intratumoral dihydrotestosterone concentrations in human endometrial carcinoma

artículo científico publicado en 2014

p62/sequestosome 1 in human colorectal carcinoma as a potent prognostic predictor associated with cell proliferation.

artículo científico publicado en 2017

Lista de obras de

11β-Prostaglandin F2α, a bioactive metabolite catalyzed by AKR1C3, stimulates prostaglandin F receptor and induces slug expression in breast cancer

17β-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer.

ARHGAP15 in Human Breast Carcinoma: A Potent Tumor Suppressor Regulated by Androgens.

Abnormal expression of miR-1 in breast carcinoma as a potent prognostic factor

Amyloid precursor protein in human breast cancer: an androgen-induced gene associated with cell proliferation

An induction of microRNA, miR-7 through estrogen treatment in breast carcinoma

Androgen and androgen-metabolizing enzymes in metastasized lymph nodes of breast cancer

Androgenic pathway in triple negative invasive ductal tumors: its correlation with tumor cell proliferation.

Androgens in human breast carcinoma ⬇️

Aryl hydrocarbon receptor in breast cancer—a newly defined prognostic marker

BUB1 immunolocalization in breast carcinoma: its nuclear localization as a potent prognostic factor of the patients

CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance

Co-expression of carcinoembryonic antigen-related cell adhesion molecule 6 and 8 inhibits proliferation and invasiveness of breast carcinoma cells

Cytochrome c1 as a favorable prognostic marker in estrogen receptor-positive breast carcinoma

Cytochrome c1 in ductal carcinoma in situ of breast associated with proliferation and comedo necrosis

Distinct nuclear receptor expression in stroma adjacent to breast tumors.

Epigenetic mechanisms regulate the prostaglandin E receptor 2 in breast cancer.

GATA4 immunolocalization in breast carcinoma as a potent prognostic predictor

Hexokinase 2 in colorectal cancer: a potent prognostic factor associated with glycolysis, proliferation and migration

Hexokinase II in breast carcinoma: a potent prognostic factor associated with hypoxia-inducible factor-1α and Ki-67.

Identification of androgen-responsive microRNAs and androgen-related genes in breast cancer

Immunolocalization of corticotropin-releasing hormone (CRH) and its receptors (CRHR1 and CRHR2) in human endometrial carcinoma: CRHR1 as a potent prognostic factor.

Immunolocalization of estrogen-producing and metabolizing enzymes in benign breast disease: comparison with normal breast and breast carcinoma

Immunolocalization of thymidylate synthase as a favorable prognostic marker in estrogen receptor-positive breast carcinoma.

Increased intratumoral androgens in human breast carcinoma following aromatase inhibitor exemestane treatment

Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment

Intratumoral estrogen concentration and expression of estrogen-induced genes in male breast carcinoma: comparison with female breast carcinoma

KLF15 in breast cancer: a novel tumor suppressor?

Krüppel-like factor 5 in human breast carcinoma: a potent prognostic factor induced by androgens

Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts

NRF2 immunolocalization in human breast cancer patients as a prognostic factor

Nucleobindin 2 (NUCB2) in human endometrial carcinoma: a potent prognostic factor associated with cell proliferation and migration

Nucleobindin 2 in human breast carcinoma as a potent prognostic factor

Nudix-type motif 2 in human breast carcinoma: a potent prognostic factor associated with cell proliferation

OLFM4, LY6D and S100A7 as potent markers for distant metastasis in estrogen receptor-positive breast carcinoma

Oestrogen-induced genes in ductal carcinoma in situ: their comparison with invasive ductal carcinoma ⬇️

Rac1 activation in human breast carcinoma as a prognostic factor associated with therapeutic resistance

Relaxin 2/RXFP1 Signaling Induces Cell Invasion via the β-Catenin Pathway in Endometrial Cancer

Retinoic Acid Receptor β: A Potential Therapeutic Target in Retinoic Acid Treatment of Endometrial Cancer

Runt-related transcription factor 2 in human colon carcinoma: a potent prognostic factor associated with estrogen receptor

Runx2 in human breast carcinoma: its potential roles in cancer progression ⬇️

TACC2 (transforming acidic coiled-coil protein 2) in breast carcinoma as a potent prognostic predictor associated with cell proliferation

The interplay of endocrine therapy, steroid pathways and therapeutic resistance: Importance of androgen in breast carcinoma

The role of 5α-reductase type 1 associated with intratumoral dihydrotestosterone concentrations in human endometrial carcinoma

p62/sequestosome 1 in human colorectal carcinoma as a potent prognostic predictor associated with cell proliferation.